MORE►
biomed
Lantern Pharma CEO Panna Sharma [Courtesy: Lantern Pharma]
Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by Lance Murray | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
by Lance Murray |
Dec 2, 2022
Dallas-based life science company ReCode Therapeutics has appointed Patricia “Trisha” Millican to its board of directors, bringing with her more than 20 years of experience in the life science industry....
MORE►
